NIH-funded research Sbir 1 grant

SmartAI Drive Safety Tool for Real-Time Drug-Use Detection

Official title: SmartDrive: AI-Powered Mobile App for Real-Time Detection of Non-Disordered Drug Use in Drivers

Funded at Tibbling Technologies LLC · NIH-11239715 · Data updated 2026-11-12

A real-time, AI-powered mobile app helps drivers check if they might be under the influence of non-disordered drugs before they drive, with a focus on school and college bus drivers.

Quick facts

Grant typeSbir 1 grant
Study typeNIH-funded research
Funding institutionTibbling Technologies LLC
NIH-funded
Lab location1 site (Redmond, United States)
Project startJune 1, 2026
Project endMay 31, 2027
Funding year2026
Award (this year)$400,000
NIH project number1R43DA064222-01
Project IDNIH-11239715 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates are school or college bus drivers and other commercial drivers who operate vehicles and could benefit from safety screening.

Less likely to help

Drivers not using such apps or those with no access to compatible devices may not benefit.

What this research studies

This project develops a real-time mobile app that uses cloud-based AI to assess whether a driver may be under the influence, helping promote safer driving. It analyzes facial and body pose features with a transformer-based framework and provides immediate feedback on fitness to drive. The system also connects with school or college administration and, when appropriate, authorities, to support safety decisions. The app is designed to be scalable and accessible across devices, aiming to reduce drug-influenced driving incidents among youth-transport workers.

Why it matters

Potential benefit: If successful, the app could improve road safety by enabling early identification of impaired drivers and prompting timely safety actions.

How similar studies have gone: Previous AI-driven safety tools show promise, but this is an early-stage deployment aimed at real-time in-vehicle use.

Where this research is happening

  • Tibbling Technologies LLC
    Redmond, United States
    Active

Researchers

  • Principal investigator: Iqbal, Asim — Tibbling Technologies LLC
  • Study coordinator: Iqbal, Asim

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Browse more
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.